1351 related articles for article (PubMed ID: 8720252)
1. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic isolated regional perfusion of the limb with carboplatin.
Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ
Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic isolated limb perfusion with intra-arterial administration of carboplatin and/or interferon-beta for the treatment of malignant melanoma of the leg.
Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
J Dermatol; 1994 Nov; 21(11):915-22. PubMed ID: 7852655
[TBL] [Abstract][Full Text] [Related]
4. Long-term functional outcome after hyperthermic isolated limb perfusion (HILP).
Knorr C; Melling N; Goehl J; Drachsler T; Hohenberger W; Meyer T
Int J Hyperthermia; 2008 Aug; 24(5):409-14. PubMed ID: 18608587
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.
Posner MC; Lienard D; Lejeune FJ; Rosenfelder D; Kirkwood J
Cancer J Sci Am; 1995; 1(4):274-80. PubMed ID: 9166488
[TBL] [Abstract][Full Text] [Related]
6. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
[TBL] [Abstract][Full Text] [Related]
7. Systemic effects of hyperthermic isolated lower limb perfusion with carboplatin and interferon-beta.
Tominaga R; Nakano T; Shibata S; Siraishi K; Nagae S; Nakayama J; Yasui H
Artif Organs; 2001 Jan; 25(1):36-41. PubMed ID: 11167557
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
Di Filippo F; Rossi CR; Santinami M; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Angelo P; Pasqualoni R; Di Filippo S
In Vivo; 2006; 20(6A):739-42. PubMed ID: 17203758
[TBL] [Abstract][Full Text] [Related]
9. The use of isolated limb perfusion to manage recurrent malignant melanoma.
Ma D; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
[TBL] [Abstract][Full Text] [Related]
10. Perilesional treatment of metastatic melanoma with interferon-beta.
Fujimura T; Okuyama R; Ohtani T; Ito Y; Haga T; Hashimoto A; Aiba S
Clin Exp Dermatol; 2009 Oct; 34(7):793-9. PubMed ID: 19438554
[TBL] [Abstract][Full Text] [Related]
11. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
13. Current status of isolated limb infusion with mild hyperthermia for melanoma.
Thompson JF; Kam PC
Int J Hyperthermia; 2008 May; 24(3):219-25. PubMed ID: 18393000
[TBL] [Abstract][Full Text] [Related]
14. [Isolated hyperthermic antiblastic perfusion in recurrent melanoma of the extremities].
De Cian F; Rainero ML; Mondini G; Spirito C; D'Addazio G; Simoni GA; Civalleri D
Minerva Chir; 1994; 49(7-8):681-91. PubMed ID: 7991176
[TBL] [Abstract][Full Text] [Related]
15. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
[TBL] [Abstract][Full Text] [Related]
17. Isolated regional limb hyperthermic perfusion as treatment for melanoma.
Loescher LJ; Leigh S
Cancer Nurs; 1984 Dec; 7(6):461-7. PubMed ID: 6568866
[No Abstract] [Full Text] [Related]
18. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma.
Tominaga R; Kohno H; Mayumi H; Shiraishi K; Nagae S; Nakayama J; Yasui H
Surg Today; 2000; 30(4):339-42. PubMed ID: 10795866
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T
Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]